Analysts See $-0.53 EPS for SunPower (SPWR); Viveve Medical (VIVE) Shorts Lowered By 3.17%

October 29, 2017 - By Marie Mckinney

Analysts expect SunPower Corporation (NASDAQ:SPWR) to report $-0.53 EPS on November, 8.They anticipate $1.09 EPS change or 194.64% from last quarter’s $0.56 EPS. After having $-0.39 EPS previously, SunPower Corporation’s analysts see 35.90% EPS growth. The stock increased 5.24% or $0.35 on October 27, reaching $7.03. About 5.00 million shares traded or 85.19% up from the average. SunPower Corporation (NASDAQ:SPWR) has declined 50.78% since October 29, 2016 and is downtrending. It has underperformed by 67.48% the S&P500.

Viveve Medical Incorporated (NASDAQ:VIVE) had a decrease of 3.17% in short interest. VIVE’s SI was 2.29 million shares in October as released by FINRA. Its down 3.17% from 2.37 million shares previously. With 109,800 avg volume, 21 days are for Viveve Medical Incorporated (NASDAQ:VIVE)’s short sellers to cover VIVE’s short positions. The SI to Viveve Medical Incorporated’s float is 37.43%. The stock decreased 1.26% or $0.07 on October 27, reaching $5.49. About 138,833 shares traded. Viveve Medical Inc (NASDAQ:VIVE) has risen 5.85% since October 29, 2016 and is uptrending. It has underperformed by 10.85% the S&P500.

SunPower Corporation is a global energy company. The company has market cap of $980.62 million. The Firm delivers complete solar solutions to residential, commercial, and power plant customers. It currently has negative earnings. The Company’s divisions include Residential Segment, Commercial Segment and Power Plant Segment.

Investors sentiment decreased to 1.05 in 2017 Q2. Its down 0.04, from 1.09 in 2017Q1. It fall, as 23 investors sold SunPower Corporation shares while 39 reduced holdings. 19 funds opened positions while 46 raised stakes. 38.32 million shares or 12.82% more from 33.97 million shares in 2017Q1 were reported. Tower Rech Limited Co (Trc) holds 0% or 209 shares in its portfolio. 47,137 were accumulated by Sg Americas Limited Liability. Guinness Atkinson Asset Mngmt holds 0.43% or 71,250 shares in its portfolio. Raymond James And invested in 271,782 shares. Credit Agricole S A holds 0% of its portfolio in SunPower Corporation (NASDAQ:SPWR) for 11,105 shares. Dnb Asset Management As holds 0% of its portfolio in SunPower Corporation (NASDAQ:SPWR) for 500,272 shares. California Public Employees Retirement System invested 0.01% of its portfolio in SunPower Corporation (NASDAQ:SPWR). Employees Retirement Association Of Colorado holds 0% of its portfolio in SunPower Corporation (NASDAQ:SPWR) for 12,586 shares. Great West Life Assurance Can reported 0% in SunPower Corporation (NASDAQ:SPWR). Moreover, Focused Wealth Mngmt Incorporated has 0% invested in SunPower Corporation (NASDAQ:SPWR). Highland Cap Management Ltd Partnership invested in 0% or 10,000 shares. Dimensional Fund Advisors L P accumulated 1.39 million shares. Pinnacle Liability Com stated it has 236 shares. Quantbot Limited Partnership has 15,986 shares. 22,761 were accumulated by Commonwealth Equity Services.

Among 20 analysts covering SunPower (NASDAQ:SPWR), 6 have Buy rating, 2 Sell and 12 Hold. Therefore 30% are positive. SunPower had 47 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Monday, September 21 by JP Morgan. The rating was maintained by Morgan Stanley with “Overweight” on Monday, December 21. The stock of SunPower Corporation (NASDAQ:SPWR) has “Outperform” rating given on Thursday, February 16 by Oppenheimer. The stock of SunPower Corporation (NASDAQ:SPWR) earned “Buy” rating by Cowen & Co on Friday, August 11. On Friday, November 6 the stock rating was initiated by Macquarie Research with “Outperform”. Mizuho initiated the shares of SPWR in report on Thursday, March 31 with “Neutral” rating. Northland Capital maintained SunPower Corporation (NASDAQ:SPWR) rating on Wednesday, July 29. Northland Capital has “Outperform” rating and $45 target. Oppenheimer downgraded the stock to “Perform” rating in Wednesday, August 10 report. The rating was maintained by RBC Capital Markets on Thursday, October 29 with “Outperform”. Barclays Capital initiated the shares of SPWR in report on Tuesday, September 1 with “Equal Weight” rating.

Viveve Medical, Inc. designs, develops, makes and markets a medical device, Geneveve, for the non-invasive treatment of vaginal laxity, for improved sexual function, and for vaginal rejuvenation. The company has market cap of $106.54 million. The Company’s, Geneveve, is a non-invasive solution for vaginal laxity, which includes three components: the Viveve System , generator housed in a table-top console), a reusable handpiece and a single-use treatment tip, as well as several other consumable accessories. It currently has negative earnings. Physicians attach the single-use treatment tip to the handpiece, which is connected to the console.